Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Lansoprazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 92Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amarin to Report Q4 and Full Year 2024 Results on March 12, 2025
    Amarin to Report Q4 and Full Year 2024 Results on March 12, 2025

    19 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/19/3028763/18362/en/Amarin-to-Report-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Host-Conference-Call-on-March-12-2025.html

    GLOBENEWSWIRE
    19 Feb 2025
    Share Share
    Amarin Appoints Peter Fishman Chief Financial Officer
    Amarin Appoints Peter Fishman Chief Financial Officer

    13 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/13/2996829/18362/en/Amarin-Appoints-Peter-Fishman-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    13 Dec 2024
    Share Share
    REDUCE-IT Subanalysis on VASCEPA®/VAZKEPA® at AHA 2024
    REDUCE-IT Subanalysis on VASCEPA®/VAZKEPA® at AHA 2024

    11 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/11/2978267/18362/en/Investigators-to-Present-New-REDUCE-IT-Subanalysis-of-VASCEPA-VAZKEPA-icosapent-ethyl-in-Patients-With-and-Without-Coronary-Artery-Disease-History-and-Mechanistic-Data-on-Eicosapen.html

    GLOBENEWSWIRE
    11 Nov 2024
    Share Share
    Macleods`s Generics Lansoprazole Receives Approval in US
    Macleods`s Generics Lansoprazole Receives Approval in US

    04 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208671

    FDA
    04 Nov 2024
    Share Share
    Amarin Reports Q3 2024 Financial Results & Provides Business Update
    Amarin Reports Q3 2024 Financial Results & Provides Business Update

    30 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/30/2972072/18362/en/Amarin-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    30 Oct 2024
    Share Share
    Amarin Announces Two Upcoming Investor Events
    Amarin Announces Two Upcoming Investor Events

    01 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//en/news-release/2024/10/01/2956053/18362/en/Amarin-Announces-Two-Upcoming-Investor-Events.html

    GLOBENEWSWIRE
    01 Oct 2024
    Share Share